# Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes

> **NCT01758471** · PHASE4 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 160 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Glipizide
- **DRUG:** Acarbose

## Key facts

- **NCT ID:** NCT01758471
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2013-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758471, "Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01758471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*